πŸ‡ΊπŸ‡Έ FDA
Patent

US 7462356

Chimeric papillomavirus-like particles

granted A61KA61K2039/5258A61K39/00

Quick answer

US patent 7462356 (Chimeric papillomavirus-like particles) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/5258, A61K39/00, A61P, A61P31/12